Effect of apolactoferrin on experimental pneumococcal otitis media

Area of Science:

• Otorhinolaryngology
• Infectious Diseases
• Pharmacology

Background:

• Otitis media, a common middle ear infection, can lead to serious inner ear complications.
• Pneumococcal infections are a frequent cause of otitis media.
• Novel nonantibiotic therapeutic strategies are needed to combat antibiotic resistance.

Purpose of the Study:

• To investigate the therapeutic effect of apolactoferrin on experimentally induced pneumococcal otitis media in a chinchilla model.
• To evaluate the impact of apolactoferrin on middle and inner ear inflammation and bacterial load.

Main Methods:

• Chinchillas with experimentally induced pneumococcal otitis media were treated with either human apolactoferrin or phosphate-buffered saline (PBS).
• Histopathologic and morphometric analyses were performed on middle and inner ear tissues.
• Bacterial counts and inflammatory cell infiltration were quantified.

Main Results:

• Apolactoferrin administration significantly reduced bacterial plate counts in middle ear effusions compared to PBS treatment (P = .005).
• The number of inflammatory cells in the round window membrane was significantly lower in the apolactoferrin group (P = .047).

Conclusions:

• Apolactoferrin demonstrated a significant reduction in bacterial load and inflammation in experimental otitis media.
• Further research is warranted to explore apolactoferrin's safety and efficacy as a nonantibiotic otitis media treatment.